Affiliation:
1. China-Japan Friendship Hospital
Abstract
Abstract
Background
Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by progressive airflow limitation and lacks clear molecular pathogenesis. We aimed to screen potential key genes and immune infiltration traits in COPD progression by bioinformatics analyses.
Methods
Transcriptome data of lung tissue samples with COPD patients were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) analysis, weighted gene co-expression network analysis (WGCNA), and Protein-protein interaction (PPI) network were used to identify key genes and interactions. GO enrichment analysis, KEGG analysis, FunRich analysis, and GSEA analysis were used to explore potential biological regulatory mechanisms. CIBERSOFT method for estimating the relative proportions of 22 human immune cells subpopulations.
Results
A total of 1230 DEGs (660 up-regulated and 570 down-regulated) were identified. WGCNA and PPI selected 8 key genes related to the severity of airflow limitation (GOLD stage), including PRPF19, ATM, CD44, KHDRBS1, RBBP7, VCL, PTEN, and BECN1, which were significantly associated with immune system functions. COPD patients with different GOLD stages have different characteristics of immune cell infiltration, with proportions of T cells (CD8+ T cells, CD4+ memory-resting T cells, CD4+ memory-activated T cells, and gamma delta T cells), B cells (memory B cells) and macrophages (M1 macrophages) upregulated in patients with GOLD stage III-IV. Furthermore, these key genes may regulate multiple immune- and inflammation-related pathways, including Cytokine-cytokine receptor interaction, ECM-receptor interaction, NF-κB signaling pathway, TNF signaling pathway, Chemokine signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Ras signaling pathway, p53 signaling pathway.
Conclusions
Our study provides new salient genes and immune landscape features associated with COPD, suggesting that these potentially key genes may mediate airflow limitation and disease progression in COPD through immune cell infiltration and immune function regulation.
Publisher
Research Square Platform LLC
Reference36 articles.
1. Global Initiative for Chronic Obstructive Lung Disease. (2023 Report) Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease. https://goldcopd.org/2023-gold-reports. Accessed Dec. 30, 2022.
2. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis;Adeloye D;Lancet Respir Med,2022
3. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;GBD 2019 Diseases and Injuries Collaborators;Lancet,2020
4. Riley CM, Sciurba FC, Diagnosis, Outpatient Management of Chronic Obstructive Pulmonary Disease. Rev JAMA. 2019;321:786–97. 10.1001/jama.2019.0131.
5. Why new biology must be uncovered to advance therapeutic strategies for chronic obstructive pulmonary disease;Nguyen JMK;Am J Physiol Lung Cell Mol Physiol,2021